Medical Expenditure for Chronic Diseases in Mexico: The Case of Selected Diagnoses Treated by the Largest Care Providers
- PMID: 26744844
- PMCID: PMC4706295
- DOI: 10.1371/journal.pone.0145177
Medical Expenditure for Chronic Diseases in Mexico: The Case of Selected Diagnoses Treated by the Largest Care Providers
Abstract
Background: Chronic diseases (CD) are a public health emergency in Mexico. Despite concern regarding the financial burden of CDs in the country, economic studies have focused only on diabetes, hypertension, and cancer. Furthermore, these estimated financial burdens were based on hypothetical epidemiology models or ideal healthcare scenarios. The present study estimates the annual expenditure per patient and the financial burden for the nine most prevalent CDs, excluding cancer, for each of the two largest public health providers in the country: the Ministry of Health (MoH) and the Mexican Institute of Social Security (IMSS).
Methods: Using the Mexican National Health and Nutrition Survey 2012 (ENSANUT) as the main source of data, health services consumption related to CDs was obtained from patient reports. Unit costs for each provided health service (e.g. consultation, drugs, hospitalization) were obtained from official reports. Prevalence data was obtained from the published literature. Annual expenditure due to health services consumption was calculated by multiplying the quantity of services consumed by the unit cost of each health service.
Results: The most expensive CD in both health institutions was chronic kidney disease (CKD), with an annual unit cost for MoH per patient of US$ 8,966 while for IMSS the expenditure was US$ 9,091. Four CDs (CKD, arterial hypertension, type 2 diabetes, and chronic ischemic heart disease) accounted for 88% of the total CDs financial burden (US$ 1.42 billion) in MoH and 85% (US$ 3.96 billion) in IMSS. The financial burden of the nine CDs analyzed represents 8% and 25% of the total annual MoH and IMSS health expenditure, respectively.
Conclusions/significance: The financial burden from the nine most prevalent CDs, excluding cancer, is already high in Mexico. This finding by itself argues for the need to improve health promotion and disease detection, diagnosis, and treatment to ensure CD primary and secondary prevention. If the status quo remains, the financial burden could be higher.
Conflict of interest statement
Figures
Similar articles
-
Measuring the burden of preventable diabetic hospitalisations in the Mexican Institute of Social Security (IMSS).BMC Health Serv Res. 2016 Aug 2;16:333. doi: 10.1186/s12913-016-1593-1. BMC Health Serv Res. 2016. PMID: 27484124 Free PMC article.
-
Costs and epidemiological changes of chronic diseases: implications and challenges for health systems.PLoS One. 2015 Mar 17;10(3):e0118611. doi: 10.1371/journal.pone.0118611. eCollection 2015. PLoS One. 2015. PMID: 25781625 Free PMC article.
-
Medical care expenditures associated with chronic kidney disease in adults with diabetes: United States 2011.Diabetes Res Clin Pract. 2015 Jul;109(1):185-90. doi: 10.1016/j.diabres.2015.04.011. Epub 2015 Apr 20. Diabetes Res Clin Pract. 2015. PMID: 25935258 Free PMC article.
-
Mexico: Health System Review.Health Syst Transit. 2020 Apr;22(2):1-222. Health Syst Transit. 2020. PMID: 33527902 Review.
-
Hong Kong's domestic health spending--financial years 1989/90 through 2004/05.Hong Kong Med J. 2008 Apr;14 Suppl 2:2-23. Hong Kong Med J. 2008. PMID: 18587162 Review.
Cited by
-
Divergences and gaps in life expectancy and health-adjusted life expectancy in Mexico: Contribution analysis of the Global Burden of Disease Study 2019.PLoS One. 2023 Nov 6;18(11):e0293881. doi: 10.1371/journal.pone.0293881. eCollection 2023. PLoS One. 2023. PMID: 37930966 Free PMC article.
-
Unmet Needs of CKD in Latin America: A Review from Expert Virtual Working Group.Kidney Int Rep. 2023 Feb 27;8(5):954-967. doi: 10.1016/j.ekir.2023.02.1082. eCollection 2023 May. Kidney Int Rep. 2023. PMID: 37180514 Free PMC article.
-
Revealing the burden of chronic kidney disease in Mexican women, 1990-2021.BMC Nephrol. 2024 Oct 12;25(1):346. doi: 10.1186/s12882-024-03797-3. BMC Nephrol. 2024. PMID: 39394115 Free PMC article.
-
Measuring the burden of preventable diabetic hospitalisations in the Mexican Institute of Social Security (IMSS).BMC Health Serv Res. 2016 Aug 2;16:333. doi: 10.1186/s12913-016-1593-1. BMC Health Serv Res. 2016. PMID: 27484124 Free PMC article.
-
Projected Impact of Mexico's Sugar-Sweetened Beverage Tax Policy on Diabetes and Cardiovascular Disease: A Modeling Study.PLoS Med. 2016 Nov 1;13(11):e1002158. doi: 10.1371/journal.pmed.1002158. eCollection 2016 Nov. PLoS Med. 2016. PMID: 27802278 Free PMC article.
References
-
- World Health Organization (2011) Global status report on noncommunicable diseases 2010. Geneva: WHO; 162 p.
-
- Murray C, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C et al. (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2197–2223. 10.1016/S0140-6736(12)61689-4 - DOI - PubMed
-
- World Economic Forum (2010) Global risk 2010. Geneva: WEC; 52 p
-
- Córdova-Villalobos JA, Barriguete-Meléndez JA, Lara-Esqueda A, Barquera S, Rosas-Peralta M, Hernandez-Avila M et al. (2008) Chronic non-communicable diseases in Mexico: epidemiologic synopsis and integral prevention. Salud Publica Mex 50:419–427. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical